Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Asha
Asha Balijepalli, Sunnyvale, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110285456 | FOUR-TERMINAL SOI MESFET BASED LOW DROPOUT REGULATOR - Embodiments of a Low Dropout (LDO) regulator are provided in which an n-channel Metal Semiconductor Field Effect Transistor (MESFET) is utilized as a pass transistor of the LDO regulator. In one embodiment, the LDO regulator is implemented on an integrated circuit die and includes an n-channel Semiconductor-on-lnsulator (SOI) MESFET pass transistor. A voltage applied to a substrate of the SOI MESFET pass transistor is controlled to configure the LDO regulator in either an ultra-low dropout voltage mode or a high Power Supply Rejection (PSR) mode. In another embodiment, the LDO regulator includes an re-channel MESFET pass transistor and a switch that operates to disconnect the MESFET pass transistor from a supply voltage of the LDO regulator when the LDO regulator is desired to be shut off. | 11-24-2011 |
Asha Keddy, Portland, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20090319642 | WIRELESS NETWORK FACILITATOR AND MONITOR - Techniques are presented for facilitating and monitoring wireless network connections. Clients and intermediate nodes are configured to interact with one another via network connections. Initially, the clients wirelessly connect to a select one of the intermediate nodes. Tests may be periodically issued to the clients and to the intermediate nodes to measure and track performance and quality of the network connections. Billing records may also be recorded and billing policies verified for client activities occurring during the network connections. | 12-24-2009 |
Asha Kulkarni-Almeida, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20080254157 | Herbal composition for inflammatory disorders - This invention relates to a novel herbal composition comprising an extract of flowering and fruiting heads of the plant, | 10-16-2008 |
| 20090269427 | HERBAL COMPOSITION FOR INFLAMMATORY DISORDERS - This invention relates to a novel herbal composition comprising an extract of flowering and fruiting heads of the plant, | 10-29-2009 |
| 20100305094 | FUSED TRICYCLIC COMPOUNDS AS INHIBITORS OF TUMOR NECROSIS FACTOR-ALPHA - Compounds of formula 1: | 12-02-2010 |
| 20100324026 | FUSED TRICYCLIC COMPOUNDS AS INHIBITORS OF TUMOR NECROSIS FACTOR-ALPHA - Compounds of formula 1: | 12-23-2010 |
Asha Peta-Thompson, Middlesex GB
| Patent application number | Description | Published |
|---|---|---|
| 20080233822 | Electrical Components and Circuits Constructed as Textiles - Electrical components are formed in a fabric during the weaving process by a series of crossing conductors in the warp and weft fibres of the fabric. Some of the crossing points provide permanent Separation of the crossing conductors, others permanent connection of the crossing conductors and others connection upon the application of pressure to the fabric. The structure provides the possibility of forming a greater range of components and more reliable component characteristics than heretofore possible. | 09-25-2008 |
Asha Syamakumari, Kerala IN
| Patent application number | Description | Published |
|---|---|---|
| 20090306240 | PROCESS FOR SYNTHESIS OF TELECHELIC URETHANE ACRYLATE UV CURABLE PRE-POLYMERIC MATERIALS - The present invention involves the design of a radiation curable organic pre polymer resin material based on urethane acrylic linkage synthesized from the natural renewable resource cardanol or a derivative thereof, for coating application. These new molecules have a faster and better curing rate compared to the starting renewable resource—cardanol. This is brought about by the hydrogen bonding of the urethane linkage which leads to a pre organization of the molecules in such a way as to bring the cross linkable double bonds closer to each other. The present invention also involves a UV curable formulation of the above mentioned resins along with 2-10 parts by weight of a photopolymerization initiator. The resin, either in a formulation or alone turns into a cross linked film upon photopolymerization in presence of photoinitiator under a UV curable radiation source like a mercury vapor pressure lamp. | 12-10-2009 |
Asha Telkar, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20090175964 | Composition for enhancing immunity - Disclosed is an edible composition for enhanced immunity comprising theanine or a source of theanine and a herb selected from Shankhpushpi, Shatavari, or a mixture thereof. | 07-09-2009 |
Asha Vellaikal, Menlo Park, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120036154 | DYNAMIC CONTENT LINKED TO CONTACT IDENTIFIERS - A system, method, device and interface for accessing dynamic contact data. The system may include associating a telephone number with one or more uniform resource locators (URLs) identifying corresponding data sources, submitting a query in a form of a telephone number, retrieving the associated one or more URLs, retrieving data from the data sources corresponding to the one or more URLs, and rendering the retrieved data. Associating may be performed by a publisher interacting with a service platform server. The one or more of submitting, retrieving and rendering may be performed by a customer interacting with a service platform server. | 02-09-2012 |
Asha Yabannavar, Lafayette, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080254026 | ANTAGONIST ANTI-CD40 MONOCLONAL ANTIBODIES AND METHODS FOR THEIR USE - Compositions and methods of therapy for treating diseases mediated by stimulation of CD40 signaling on CD40-expressing cells are provided. The methods comprise administering a therapeutically effective amount of an antagonist anti-CD40 antibody or antigen-binding fragment thereof to a patient in need thereof. The antagonist anti-CD40 antibody or antigen-binding fragment thereof is free of significant agonist activity, but exhibits antagonist activity when the antibody binds a CD40 antigen on a human CD40-expressing cell. Antagonist activity of the anti-CD40 antibody or antigen-binding fragment thereof beneficially inhibits proliferation and/or differentiation of human CD40-expressing cells, such as B cells. | 10-16-2008 |
| 20080269221 | ANTIBACTERIAL AGENTS - Antibacterial compounds of formula I are provided: | 10-30-2008 |
| 20090247506 | Antibacterial agents - Antibacterial compounds of formula I are provided: | 10-01-2009 |
| 20100324025 | Antibacterial Agents - Antibacterial compounds of formula I are provided: | 12-23-2010 |
| 20110172174 | Antibacterial agents - Antibacterial compounds of formula I are provided: | 07-14-2011 |